Table 3. Comparison of the median cortisol levels of survivors and non-survivors.
Groups | Median cortisol level | Interquartile range | Groups | P-value |
---|---|---|---|---|
Group 1 survivor (n = 123) | 16.3 | 13.45-18.92 | Group 1 non-survivor | 0.624 |
Group 2 survivor | < 0.001 | |||
Group 2 non-survivor | < 0.001 | |||
Group 1 non-survivor (n = 17) | 18.4 | 16.11-19.56 | Group 1 survivor | 0.624 |
Group 2 survivor | 0.006 | |||
Group 2 non-survivor | < 0.001 | |||
Group 2 survivor (n = 100) | 19.05 | 17.76-22.54 | Group 1 survivor | < 0.001 |
Group 1 non-survivor | 0.006 | |||
Group 2 non-survivor | < 0.001 | |||
Group 2 non-survivor (n = 44) | 31.8 | 29.64-34.92 | Group 1 survivor | < 0.001 |
Group 1 non-survivor | < 0.001 | |||
Group 2 survivor | < 0.001 |
Group 1 = COVID-19 negative patients, Group 2 = COVID-19 positive patients
Comparisons between groups were made using the Kruskal-Wallis test and one-way analysis of variance. Multiple comparisons between groups were made using the post-hoc Tamhane T2 test.
P < 0.05 = significant (shown in bold).